Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 1/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2904265 | 0.87 | ANPEP (0.61) | RIPK1ANPEPALDH1A1KMT2AEPHX2 | |
| SCHEMBL31425839 | 0.84 | ANPEP (0.58) | RIPK1ANPEPTSHRALDH1A1KMT2A | |
| SCHEMBL13212299 | 0.83 | TSHR (0.52) | TSHRALDH1A1KMT2A | |
| SCHEMBL2913379 | 0.81 | ALDH1A1 (0.75) | ANPEPTSHRALDH1A1KMT2ANPC1 | |
| SCHEMBL2910863 | 0.81 | SLC1A2 (0.59) | RIPK1TSHRALDH1A1LMNAMAPT | |
| SCHEMBL1397074 | 0.80 | RIPK1 (0.55) | RIPK1ANPEPTSHRALDH1A1KMT2A | |
| SCHEMBL12863555 | 0.79 | ANPEP (0.56) | ANPEPTSHRALDH1A1KMT2AMAPT | |
| SCHEMBL21004152 | 0.79 | TSHR (0.80) | ANPEPTSHRALDH1A1KMT2ANPC1 | |
| SCHEMBL2749015 | 0.78 | RIPK1 (0.52) | RIPK1ANPEPTSHRALDH1A1KMT2A | |
| SCHEMBL2905338 | 0.77 | RIPK1 (0.62) | RIPK1ANPEPALDH1A1KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1586552-B1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL IND CO (JP) | 2010-08-25 | — | — | EP | disclosed |
| CN-100503551-C | Process for producing benzylamine derivative | IHARA CHEMICAL IND CO (JP) | 2009-06-24 | — | — | CN | disclosed |
| US-7326813-B2 | Process for producing benzylamine derivative | IHARA CHEMICAL INDUSTRY (JP) | 2008-02-05 | — | — | US | disclosed |
| US-20060155141-A1 | Process for producing benzylamine derivative | ITO AKINORI | 2006-07-13 | — | — | US | disclosed |
| CN-1802343-A | Process for producing benzylamine derivative | IHARA CHEMICAL IND CO (JP) | 2006-07-12 | — | — | CN | disclosed |
| EP-1586552-A1 | PROCESS FOR PRODUCING BENZYLAMINE DERIVATIVE | IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) | 2005-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060155141-A1 | Process for producing benzylamine derivative | BRD7, BRD1, BRD2 | RIPK1 4019/4885ANPEP 1249/4885TSHR 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.